Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia ; volume:16 ; number:1 ; day:3 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
Journal of hematology & oncology ; 16, Heft 1 (3.8.2023), 1-12, 12.2023

Creator: Bahaj, Waled
Kewan, Tariq
Gurnari, Carmelo
Durmaz, Arda
Ponvilawan, Ben
Pandit, Ishani
Kubota, Yasuo
Ogbue, Olisaemeka D.
Zawit, Misam
Madanat, Yazan
Bat, Taha
Balasubramanian, Suresh K.
Awada, Hussein
Ahmed, Ramsha
Mori, Minako
Meggendorfer, Manja
Haferlach, Torsten
Visconte, Valeria
Maciejewski, Jaroslaw P.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13045-023-01480-y

URN: urn:nbn:de:101:1-2023110110042955820493

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bahaj, Waled
Kewan, Tariq
Gurnari, Carmelo
Durmaz, Arda
Ponvilawan, Ben
Pandit, Ishani
Kubota, Yasuo
Ogbue, Olisaemeka D.
Zawit, Misam
Madanat, Yazan
Bat, Taha
Balasubramanian, Suresh K.
Awada, Hussein
Ahmed, Ramsha
Mori, Minako
Meggendorfer, Manja
Haferlach, Torsten
Visconte, Valeria
Maciejewski, Jaroslaw P.
SpringerLink (Online service)

Other Objects (12)

Multiparameter prediction of myeloid neoplasia risk

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Functional classification of TP53 mutations in acute myeloid leukemia

What have we learned about TP53-mutated acute myeloid leukemia?

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix

Multiparameter prediction of myeloid neoplasia risk

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Functional classification of TP53 mutations in acute myeloid leukemia

What have we learned about TP53-mutated acute myeloid leukemia?

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix

Multiparameter prediction of myeloid neoplasia risk

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Functional classification of TP53 mutations in acute myeloid leukemia

What have we learned about TP53-mutated acute myeloid leukemia?

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Multiparameter prediction of myeloid neoplasia risk

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Functional classification of TP53 mutations in acute myeloid leukemia

What have we learned about TP53-mutated acute myeloid leukemia?

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix

Multiparameter prediction of myeloid neoplasia risk

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Functional classification of TP53 mutations in acute myeloid leukemia

What have we learned about TP53-mutated acute myeloid leukemia?

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix

Multiparameter prediction of myeloid neoplasia risk

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Functional classification of TP53 mutations in acute myeloid leukemia

What have we learned about TP53-mutated acute myeloid leukemia?

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix

Related objects

Reset password